FOS and central nervous system cancer: We demonstrated a notable increase of the reporter activity for TRAILpr-Luc in U87MG cells and modest increase in U118MG cells after CBD treatment reflecting a possible role of AP1 activation for regulation of the TRAIL promoter activity in glioma cells (Figure 8B).